AMIS
SMSR
  1. Home
  2. Scores
  3. RISQUE CARDIOVASCULAIRE / CORONARIEN

Scores

Menu

Bibliographie


Pour les scores : liste des documents sources


  • Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83(1):356-62.
  • Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002;105(3):310-5.
  • Assmann G, Schulte H, Cullen P, Seedorf U. Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study. Eur J Clin Invest 2007;37(12):925-32.
  • Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24(11):987-1003.
  • D'Agostino RB, Sr., Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Jama 2001;286(2):180-7. 24)
  • MarrugatJ et al. An adaptation of the Framingham coronary heart disease risk function to Europ Mediterranean area. J Epidemiol Community Health 2003; 57: 634-38
  • D'Agostino RB, Sr., Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117(6):743-53.
  • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001;285(19):2486-97.
  • Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. Bmj 2008;336(7659):1475-82.
  • Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. Jama 2007;297(6):611-9.
  • Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008;118(22):2243-51, 4p following 51.
  • Romanens M, Ackermann F, Abay M, Szucs T, Schwenkglenks M. Agreement of Swiss-adapted international and European guidelines for the assessment of global vascular risk and for lipid lowering interventions. Cardiovasc Drugs Ther 2009;23(3):249-54.
  • Sullivan LM, Massaro JM, D'Agostino RB, Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 2004;23(10):1631-60.
  • Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-47.
  • Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007;93(2):172-6.


Revues générales


  • Cooper A, Nherera L, Calvert N, O’Flynn N, Turnbull N, Robson J, Camosso-Stefinovic J, Rule C, Browne N, Ritchie G, Stokes T, Mannan R, Brindle P, Gill P,Gujral R, Hogg M, Marshall T, Minhas R, Pavitt L, Reckless J, Rutherford A,Thorogood M, Wood D(2008) Clinical Guidelines and Evidence Review for Lipid Modification: cardiovascular risk assessment and the primary and secondary prevention of cardiovascular disease. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners.
  • http://guidance.nice.org.uk/CG67
    Une revue publiée en 2008 et revue en 2010, à l’exhaustivité impressionnante, dans le cadre du National Institute for Health and Clinical Excellence (NICE) du National Health Service (Grande-Bretagne).
  • Matheny M, McPheeters ML, Glasser A, Mercaldo N, Weaver RB, Jerome RN, Walden R, McKoy JN, Pritchett J, Tsai C. Systematic Review of Cardiovascular Disease Risk Assessment Tools. Evidence Synthesis No. 85. AHRQ Publication No. 11-05155-EF-1. Rockville, MD: Agency for Healthcare Research and Quality (http://www.ahrq.gov); May 2011.
    Revue publiée en 2011 et offrant un panorama complet sur tout ce qui a trait aux scores de risque cardiovasculaire.
  • Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol 2010;55(12):1169-77.
  • Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009;54(14):1209-27.Cooney MT, Dudina A, D'Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 2010;122(3):300-10.
  • Dent TH. Predicting the risk of coronary heart disease I. The use of conventional risk markers. Atherosclerosis 2010;213(2):345-51.
  • Hobbs FD, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. Qjm 2010;103(10):727-39.